236 related articles for article (PubMed ID: 24938861)
1. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis.
Spoorenberg SM; Bos WJ; Heijligenberg R; Voorn PG; Grutters JC; Rijkers GT; van de Garde EM
BMC Infect Dis; 2014 Jun; 14():335. PubMed ID: 24938861
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
Vissink CE; Huijts SM; de Wit GA; Bonten MJ; Mangen MJ
BMC Infect Dis; 2016 Sep; 16(1):466. PubMed ID: 27589847
[TBL] [Abstract][Full Text] [Related]
3. In-hospital mortality associated with community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus: a matched-pair cohort study.
Sakamoto Y; Yamauchi Y; Jo T; Michihata N; Hasegawa W; Takeshima H; Matsui H; Fushimi K; Yasunaga H; Nagase T
BMC Pulm Med; 2021 Nov; 21(1):345. PubMed ID: 34732194
[TBL] [Abstract][Full Text] [Related]
4. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
Zhou QT; He B; Zhu H
Value Health; 2009; 12(1):40-6. PubMed ID: 18637052
[TBL] [Abstract][Full Text] [Related]
5. Trends in mortality and medical spending in patients hospitalized for community-acquired pneumonia: 1993-2005.
Ruhnke GW; Coca-Perraillon M; Kitch BT; Cutler DM
Med Care; 2010 Dec; 48(12):1111-6. PubMed ID: 21063230
[TBL] [Abstract][Full Text] [Related]
6. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
7. Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey.
Chen L; Zhou F; Li H; Xing X; Han X; Wang Y; Zhang C; Suo L; Wang J; Yu G; Wang G; Yao X; Yu H; Wang L; Liu M; Xue C; Liu B; Zhu X; Li Y; Xiao Y; Cui X; Li L; Uyeki TM; Wang C; Cao B;
BMJ Open; 2018 Feb; 8(2):e018709. PubMed ID: 29449294
[TBL] [Abstract][Full Text] [Related]
8. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
Orrick JJ; Segal R; Johns TE; Russell W; Wang F; Yin DD
Pharmacoeconomics; 2004; 22(11):751-7. PubMed ID: 15250752
[TBL] [Abstract][Full Text] [Related]
9. Determinants of hospital costs in community-acquired pneumonia.
Reyes S; Martinez R; Vallés JM; Cases E; Menendez R
Eur Respir J; 2008 May; 31(5):1061-7. PubMed ID: 18448502
[TBL] [Abstract][Full Text] [Related]
10. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States.
Kaplan V; Angus DC; Griffin MF; Clermont G; Scott Watson R; Linde-Zwirble WT
Am J Respir Crit Care Med; 2002 Mar; 165(6):766-72. PubMed ID: 11897642
[TBL] [Abstract][Full Text] [Related]
11. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
Personne V; Chevalier J; Buffel du Vaure C; Partouche H; Gilberg S; de Pouvourville G
Vaccine; 2016 Apr; 34(19):2275-80. PubMed ID: 26979138
[TBL] [Abstract][Full Text] [Related]
12. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
13. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae.
Sun HK; Nicolau DP; Kuti JL
Chest; 2006 Sep; 130(3):807-14. PubMed ID: 16963679
[TBL] [Abstract][Full Text] [Related]
14. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis.
Rozenbaum MH; Mangen MJ; Huijts SM; van der Werf TS; Postma MJ
Vaccine; 2015 Jun; 33(28):3193-9. PubMed ID: 25981488
[TBL] [Abstract][Full Text] [Related]
15. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
Divino V; Schranz J; Early M; Shah H; Jiang M; DeKoven M
Curr Med Res Opin; 2020 Jan; 36(1):151-160. PubMed ID: 31566005
[No Abstract] [Full Text] [Related]
16. Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.
Egger ME; Myers JA; Arnold FW; Pass LA; Ramirez JA; Brock GN
BMC Med Inform Decis Mak; 2016 Mar; 16():34. PubMed ID: 26976388
[TBL] [Abstract][Full Text] [Related]
17. Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
Cortoos PJ; Gilissen C; Laekeman G; Peetermans WE; Leenaers H; Vandorpe L; Simoens S
Scand J Infect Dis; 2013 Mar; 45(3):219-26. PubMed ID: 23113827
[TBL] [Abstract][Full Text] [Related]
18. Hospitalized low-risk community-acquired pneumonia: outcome and potential for cost-savings.
Hoe LK; Keang LT
Respirology; 1999 Sep; 4(3):307-9. PubMed ID: 10489681
[TBL] [Abstract][Full Text] [Related]
19. Treatment costs of community-acquired pneumonia in an employed population.
Colice GL; Morley MA; Asche C; Birnbaum HG
Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
[TBL] [Abstract][Full Text] [Related]
20. Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.
Clark LC; Davis CW
Am J Health Syst Pharm; 2000 Nov; 57 Suppl 3():S10-3. PubMed ID: 11098314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
